2 Citazioni (Scopus)


This study was carried out in an attempt to assess the pattern of cathepsin D variations induced by Doxorubicin (DXR) and to clarify the role possibly played by this endopeptidase in the onset of anthracyclines-induced cardiotoxicity. We evaluated the variations in both total and 'sedimentable' enzyme activity of cathepsin D in the heart of mice treated once a week for up to 8 weeks with DXR (4 mg/kg i.v.b.wt.) and sacrificed 12h, 3 and 6 days after 1, 4, 5 and 8 administrations. Our results show that significant but transitory changes in both total and sedimentable activity of cathepsin D occur after each administration and decline after prolonged treatments. These data do not suggest, but do not exclude, a direct involvement of cathepsin D in the onset of DXR-induced cardiotoxicity: these phenomena might in fact be merely secondary to an increased catabolic activity of cathepsin D following an enhanced metabolic turnover of mitochondrial and myofibrillar protein damaged by DXR. This finding seems however quite interesting because cathepsin D variations might represent one of the long looked for biochemical marker of anthracyclines cardiotoxicity.
Lingua originaleEnglish
pagine (da-a)1471-1472
Numero di pagine2
RivistaMedical Science Research
Stato di pubblicazionePublished - 1987

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.1300.1300???


Entra nei temi di ricerca di 'Cathepsin D: A possible biochemical marker for anthracycline cardiomyopathy'. Insieme formano una fingerprint unica.

Cita questo